August 2025

Webjet has announced it will utilise its surplus capital to acquire Locomote, a small Melbourne-based travel company, and return $25 million to shareholders via an on-market buyback. Webjet is an online travel agent that allows customers to book flights, accommodation, and other travel services. Last year, it demerged its hotel booking aggregator business and has

Accent Group has reported a slowdown in sales growth for the 2025 financial year, with sales increasing by just 1.5 per cent to $1.5 billion. The ASX-listed retailer, valued at $1 billion, operates over 900 stores across various chains, including Hype DC, The Athlete’s Foot, Platypus, Stylerunner and Nude Lucy. Accent Group specialises in the

Latitude Group has reported a substantial increase in first-half profit, driven by higher lending and increased spending volumes. The company announced a dividend payout as receivables reached a five-year high. Statutory net profit after tax surged to $39.7 million for the six months ending June 30, representing a 341 per cent increase compared to the

Microequities Asset Management Group Limited (ASX:MAM), an Australian investment management firm specialising in listed industrial small and microcap companies, has released its FY25 financial results, showcasing significant growth in key metrics. The company reported a 19% increase in Net Profit After Tax (NPAT) to $7.1 million and a 39% increase in operating profit to $10.4

Microequities Asset Management Group Limited (MAM), an ASX-listed company managing investment funds, has announced a 19.3% increase in profit from ordinary activities after tax, attributable to owners, reaching $7,149,776 for the year ended 30 June 2025. This compares to $5,990,697 in the previous corresponding period. Revenue from ordinary activities also saw a rise of 9.3%,

Siren Gold Limited (ASX: SNG), a New Zealand-focused gold exploration and development company, has announced it has secured firm commitments to raise $4 million through a placement to new and existing sophisticated and institutional investors. The company’s flagship asset, the Sams Creek Gold Project, hosts a JORC Mineral Resource Estimate (MRE) of 824,000 ounces of

Neurizon Therapeutics Limited (ASX: NUZ), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for its Clinical Hold Complete Response (CHCR) to the Investigational New Drug (IND) application for NUZ-001. NUZ-001 is the company’s lead investigational therapy